A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.
Researchers link increased screen time in children and adolescents to higher cardiometabolic and cardiovascular risk, with sleep duration identified as a key moderating factor.
Blinking decreases and eye strain increases during one hour of smartphone use, with dynamic screen changes from social media reels creating the highest visual load.